Public market insider buying at Sernova (T:SVA)

Brett Alexander Whalen, a Director, acquired 250,000 Common Shares on a direct ownership basis at a price of $0.950 on July 26th, 2023. This represents a $237,500 investment into the company's shares and an account share holdings change of 10.4%.

Sernova is in the Medical Equipment, Supplies & Distribution Sub Industry Group under the Healthcare Sector.

Sernova Corp. is a Canada-based clinical-stage regenerative medicine therapeutics company. The Company is focused on developing and commercializing regenerative medicine therapeutics, including its Cell Pouch and associated technologies, including therapeutic cells and local cellular immune protection. The Cell Pouch is a scalable and implantable medical device. The Cell Pouch is designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of multiple chronic diseases, such as diabetes, hemophilia and thyroid disease. Its Cell Pouch combines with immune protected therapeutic cells, offers a protection from immune system attack. Its regenerative medicine therapeutic approach provides cell therapies, where the cells transplanted within an organ-like the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.